MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    A staged screening paradigm to identify people at risk of Parkinson’s disease in the Parkinson’s Progression Markers Initiative

    E. Brown, A. Siderowf, T. Simuni, T. Sherer, M. Brumm, C. Caspell-Garcia, R. Kurth, C. Gochanour, M. Kuhl, M. Korell, J. Valverde Twiggs, C. Stanley, L. Concha, C. Soto, K. Marek, C. Tanner (San Francisco, USA)

    Objective: To identify people at risk of Parkinson’s disease (PD) using a staged-screening paradigm. Background: Early recognition of people with PD may be essential to…
  • 2023 International Congress

    Risk of Parkinson’s Disease due to Helicobacter Pylori and High Salt Consumption

    V. Balendra (Park Ridge, USA)

    Objective: The association between excessive salt consumption, susceptibility to H. pylori infection and risk of Parkinson's disease will be analyzed through scientific studies. Background: The…
  • 2023 International Congress

    Assessment of non-motor symptoms of Parkinson’s disease after the repeated courses of the autologous stem cell therapy

    V. Chyzhyk, A. Boika, V. Ponomarev (Minsk, Belarus)

    Objective: To evaluate the influence of the second course of the cell therapy on the dynamics of the non-motor symptoms in patients with PD 6…
  • 2023 International Congress

    The mGlu2 positive allosteric modulator AZD8529 alleviates L-DOPA-induced dyskinesia and psychosis-like behaviours in the parkinsonian marmoset

    J. Shaqfah, I. Frouni, C. Kwan, D. Bédard, S. Nuara, J. Gourdon, A. Hamadjida, P. Huot (Montreal, Canada)

    Objective: To assess the effect of the metabotropic glutamate 2 (mGlu2) receptor positive allosteric modulator (PAM) AZD8529 on L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesia and psychosis-like behaviours (PLBs)…
  • 2023 International Congress

    Strategic decision-making in Parkinson’s disease with fatigue

    C. Pauletti, D. Mannarelli, F. Milano, A. Maffucci, A. Petritis, F. Fattapposta (Rome, Italy)

    Objective: To assess response inhibition and strategic decision-making abilities associated with fatigue in Parkinson’s disease (PD). Background: PD-related fatigue is defined as a feeling of…
  • 2023 International Congress

    Effect of dietary caffeine on brain dopamine transporter binding in Parkinson’s disease

    E. Saarinen, T. Kuusimäki, K. Lindholm, EA. Honkanen, T. Noponen, M. Seppänen, K. Murtomäki, T. Mertsalmi, E. Jaakkola, E. Mäkinen, M. Eklund, S. Nuuttila, R. Levo, KR. Chaudhuri, A. Antonini, J. Joutsa, F. Scheperjans, V. Kaasinen (Turku, Finland)

    Objective: To investigate the relationship between dietary caffeine intake and striatal dopamine function over the progression of Parkinson’s disease (PD). Background: The association between high…
  • 2023 International Congress

    Intercultural differences in patient and clinician perceptions of MDS-UPDRS in Parkinson’s disease

    V. Kaasinen, S. Luo, P. Martinez-Martin, C. Goetz, G. Stebbins (Turku, Finland)

    Objective: To explore culturally dependent differences between patient- and clinician-based evaluations of Parkinson’s disease (PD) motor symptoms. Background: Effects of multiple demographic factors on Movement…
  • 2023 International Congress

    Prognostic significance of peripheral neutrophils and lymphocytes in early Parkinson’s disease

    JS. Jun, R. Kim (Seoul, Republic of Korea)

    Objective: To explore whether peripheral blood neutrophils and lymphocytes are associated with longitudinal motor and cognitive decline in patients with early Parkinson’s disease (PD) and,…
  • 2023 International Congress

    Sensitivity, consistency and test-retest reliability of home-based freezing of gait-provoking tests in people with Parkinson’s disease

    D. Zoetewei, P. Ginis, M. Gilat, T. Herman, M. Brozgol, P. Thumm, J. Hausdorff, A. Nieuwboer, N. D'Cruz (Leuven, Belgium)

    Objective: To evaluate the sensitivity, consistency and test-retest reliability of several freezing of gait (FOG)-provoking tests in the homes of people with Parkinson’s disease (PD)…
  • 2023 International Congress

    Genome Wide Association Studies using TRACTOR reveals new associated loci with Parkinson Disease in a Latino Cohort

    T. Leal, V. Borda, M. Gouveia, M. Inca-Martinez, E. Mason, D. Loesch, A. Horimoto, E. Sarihan, M. Cornejo-Olivas, L. Torres, P. Mazzetti, C. Cosentino, E. Sarapura-Castro, A. Rivera-Valdivia, A. Medina, E. Dieguez, V. Raggio, A. Lescano, V. Tumas, V. Borges, H. Ferraz, C. Rieder, A. Schumacher-Schuh, B. Santos-Lobato, C. Velez-Pardo, M. Jimenez-Del-Rio, F. Lopera, S. Moreno, P. Chana-Cuevas, W. Fernandez, G. Arboleda, H. Arboleda, C. Arboleda-Bustos, D. Yearout, C. Zabetian, T. Thornton, T. O'Connor, I. Mata (Cleveland, USA)

    Objective: Our objective was using TRACTOR[1], which performs Genome Wide Association Study (GWAS) including Local Ancestry (LA) information, in Parkinson Disease (PD) using data from…
  • « Previous Page
  • 1
  • …
  • 179
  • 180
  • 181
  • 182
  • 183
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley